Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder

Psychoneuroendocrinology

Volumn 67, Issue , 2016, Pages 142-152

  Eisenlohr Moul, Tory A ^a   Rubinow, David R ^a   Schiller, Crystal E ^a   Johnson, Jacqueline L ^b   Leserman, Jane ^a   Girdler, Susan S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

Abuse; Estradiol; Ovarian steroid hormones; Premenstrual dysphoric disorder; Progesterone

Indexed keywords

ESTRADIOL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; ANXIETY DISORDER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; LIFE STRESS; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENSTRUAL CYCLE; MENSTRUALLY RELATED MOOD DISORDER; MENSTRUATION DISORDER; MOOD DISORDER; PATHOPHYSIOLOGY; PHYSICAL ABUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUAL ABUSE; SOCIAL PSYCHOLOGY; SYMPTOM; BLOOD; CHILD ABUSE SURVIVOR; PREMENSTRUAL SYNDROME; PSYCHOLOGY; YOUNG ADULT;

ADULT; ADULT SURVIVORS OF CHILD ABUSE; ESTRADIOL; FEMALE; HUMANS; MENSTRUAL CYCLE; PREMENSTRUAL SYNDROME; PROGESTERONE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84958521584     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2016.01.026     Document Type: Article

References (48)

1. Bandelow B., Krause J., Wedekind D., Broocks A., Hajak G., Rüther E. Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls. Psychiatry Res. 2005, 134(2):169-179. 10.1016/j.psychres.2003.07.008.
2. Bartz J., Simeon D., Hamilton H., Kim S., Crystal S., Braun A., Vicens V., Hollander E. Oxytocin can hinder trust and cooperation in borderline personality disorder. Soc. Cognit. Affect. Neurosci. 2010, nsq085.
3. Bartz J.A., Zaki J., Bolger N., Ochsner K.N. Social effects of oxytocin in humans: context and person matter. Trends Cognit. Sci. 2011, 15(7):301-309.
4. Bartz J.A., Zaki J., Ochsner K.N., Bolger N., Kolevzon A., Ludwig N., Lydon J.E. Effects of oxytocin on recollections of maternal care and closeness. Proc. Natl. Acad. Sci. 2010, 107(50):21371-21375.
5. Bertone-Johnson E.R., Whitcomb B.W., Missmer S.A., Manson J.E., Hankinson S.E., Rich-Edwards J.W. Early life emotional. physical, and sexual abuse and the development of premenstrual syndrome: a longitudinal study. J. Women's Health 2014, 140806113637009. 10.1089/jwh.2013.4674.
6. Bless E.P., McGinnis K.A., Mitchell A.L., Hartwell A., Mitchell J.B. The effects of gonadal steroids on brain stimulation reward in female rats. Behav. Brain Res. 1997, 82(2):235-244. 10.1016/S0166-4328 (96) 00129-5.
7. Bradshaw C.P., Garbarino J. Social cognition as a mediator of the influence of family and community violence on adolescent development: implications for intervention. Ann. N. Y. Acad. Sci. 2004, 1036(1):85-105.
8. Brown C.S., Ling F.W., Andersen R.N., Farmer R.G., Arheart K.L. Efficacy of depot leuprolide in premenstrual-syndrome-effect of symptom severity and type in a controlled trial. Obstet. Gynecol. 1994, 84(5):779-786.
9. Bunevicius A., Leserman J., Girdler S.S. Hypothalamic-pituitary-thyroid axis function in women with a menstrually related mood disorder: association with histories of sexual abuse. Psychosom. Med. 2012, 74(8):810-816. 10.1097/PSY.0b013e31826c3397.
10. Cheng Y.J., Karavolas H.J. Conversion of progesterone to 5-pregnane-3,20-dione and 3-hydroxy-5-pregnan-20-one by rat medial basal hypothalami and the effects of estradiol and stage of estrous cycle on the conversion. Endocrinology 1973, 93(5):1157-1162. 10.1210/endo-93-5-1157.
11. Crowley S.K., Girdler S.S. Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?. Psychopharmacology 2014, 231(17):3619-3634. 10.1007/s00213-014-3572-8.
12. Cullinan W.E., Ziegler D.R., Herman J.P. Functional role of local GABAergic influences on the HPA axis. Brain Struct. Funct. 2008, 213(1-2):63-72. 10.1007/s00429-008-0192-2.
13. Ehlert U. Enduring psychobiological effects of childhood adversity. Psychoneuroendocrinology 2013, 1-8. 10.1016/j.psyneuen.2013.06.007.
14. Eisenlohr-Moul T.A., DeWall C.N., Girdler S.S., Segerstrom S.C. Ovarian hormones and borderline personality disorder features: preliminary evidence for interactive effects of estradiol and progesterone. Biol. Psychol. 2015, 109:37-52. 10.1016/j.biopsycho.2015.03.016.
15. Enders C.K., Tofighi D. Centering predictor variables in cross-sectional multilevel models: a new look at an old issue. Psychol. Methods 2007, 12(2):121.
16. Endicott J., Nee J., Harrison W. Daily record of severity of problems (DRSP): reliability and validity. Arch. Women's Mental Health 2006, 9(1):41-49. 10.1007/s00737-005-0103-y.
17. Girdler S.S. Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls. Psychosom. Med. 2003, 65(5):849-856. 10.1097/01.PSY.0000088593.38201.CD.
18. Girdler S.S., Leserman J., Bunevicius R., Klatzkin R., Pedersen C.A., Light K.C. Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder. Health Psychol. 2007, 26(2):201-213. 10.1037/0278-6133.26.2.201.
19. Girdler S.S., Thompson K.S., Light K.C., Leserman J., Pedersen C.A., Prange A.J. Historical sexual abuse and current thyroid axis profiles in women with premenstrual dysphoric disorder. Psychosom. Med. 2004, 66(3):403-410.
20. Gordon J.L., Girdler S.S., Meltzer-Brody S.E., Stika C.S., Thurston R.C., Clark C.T., et al. Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. Am. J. Psychiatry 2015, 172(3):227-236. 10.1176/appi.ajp.2014.14070918.
21. Guillermo C.J., Manlove H.A., Gray P.B., Zava D.T., Marrs C.R. Female social and sexual interest across the menstrual cycle: the roles of pain, sleep and hormones. BMC Women's Health 2010, 10(1):19. 10.1186/1472-6874-10-19.
22. Halbreich U., Borenstein J., Pearlstein T., Kahn L.S. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003, 28:1-23. 10.1016/S0306-4530(03) 00098-2.
23. Hammarbäck S., Bäckström T. Induced anovulation as treatment of premenstrual tension syndrome: a double-blind cross-over study with GnRH-agonist versus placebo. Acta Obstet. Gynecol. Scand. 2009, 67(2):159-166.
24. Heim C., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008, 33(6):693-710. 10.1016/j.psyneuen.2008.03.008.
25. Klatzkin R.R., Bunevicius A., Forneris C.A., Girdler S. Menstrual mood disorders are associated with blunted sympathetic reactivity to stress. J. Psychosom. Res. 2014, 76(1):46-55. 10.1016/j.jpsychores.2013.11.002.
26. Leserman J., Li Z., Drossman D.A., Toomey T.C., Nachman G., Glogau L. Impact of sexual and physical abuse dimensions on health status: development of an abuse severity measure. Psychosom. Med. 1997, 59(2):152-160.
27. Liu J., Bisschop P.H., Eggels L., Foppen E., Fliers E., Zhou J.N., Kalsbeek A. Intrahypothalamic estradiol modulates hypothalamus-pituitary-adrenal-axis activity in female rats. Endocrinology 2012, 153(7):3337-3344. 10.1210/en.2011-2176.
28. Maner J.K., Miller S.L. Hormones and social monitoring: menstrual cycle shifts in progesterone underlie women's sensitivity to social information. Evol. Hum. Behav. 2014, 35(1):9-16.
29. McEwen B. Estrogen actions throughout the brain. Recent Prog. Horm. Res. 2002, 57:357-384.
30. Messman-Moore T.L., Long P.J. The role of childhood sexual abuse sequelae in the sexual revictimization of women: an empirical review and theoretical reformulation. Clin. Psychol. Rev. 2003, 23(4):537-571.
31. Morrow A.L., Suzdak P.D., Paul S.M. Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur. J. Pharmacol. 1987, 142(3):483-485. 10.1016/0014-2999(87) 90094-X.
32. Muse K.N., Cetel N.S., Futterman L.A., Yen S.S.C. The premenstrual syndrome. N. Engl. J. Med. 1984, 311(21):1345-1349. 10.1056/NEJM198411223112104.
33. Neumann D.A., Houskamp B.M., Pollock V.E., Briere J. The long-term sequelae of childhood sexual abuse in women: a meta-analytic review. Child Maltreat. 1996, 1(1):6-16.
34. Patchev V.K., Almeida O. Gonadal steroids exert facilitating and buffering effects on glucocorticoid-mediated transcriptional regulation of corticotropin-releasing hormone and corticosteroid receptor genes in rat brain. J. Neurosci. 1996, 16(21):7077-7084.
35. Patchev V.K., Shoaib M., Holsboer F., Almeida O.F.X. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience 1994, 62(1):265-271. 10.1016/0306-4522(94) 90330-1.
36. Perkonigg A., Yonkers K.A., Pfister H., Lieb R., Wittchen H.U. Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder. J. Clin. Psychiatry 2004, 65(10):1314-1322.
37. Pilver C.E., Levy B.R., Libby D.J., Desai R.A. Posttraumatic stress disorder and trauma characteristics are correlates of premenstrual dysphoric disorder. Arch. Women's Mental Health 2011, 14(5):383-393. 10.1007/s00737-011-0232-4.
38. Redei E., Freeman E.W. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocrinology 1995, 20(3):259-267. 10.1016/0306-4530(94) 00057-H.
39. Roca C.A., Schmidt P.J., Altemus M., Deuster P., Danaceau M.A., Putnam K., Rubinow D.R. Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls. J. Clin. Endocrinol. Metab. 2003, 88(7):3057-3063. 10.1210/jc.2002-021570.
40. Roney J.R., Simmons Z.L. Hormonal predictors of sexual motivation in natural menstrual cycles. Horm. Behav. 2013, 63(4):636-645. 10.1016/j.yhbeh.2013.02.013.
41. Schiller C.E., O'Hara M.W., Rubinow D.R., Johnson A.K. Estradiol modulates anhedonia and behavioral despair in rats and negative affect in a subgroup of women at high risk for postpartum depression. Physiol. Behav. 2013, 119:1-8. 10.1016/j.physbeh.2013.06.009.
42. Schiller C.E., Schmidt P.J., Rubinow D.R. Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology 2014, 231(17):3557-3567. 10.1007/s00213-014-3599-x.
43. Schmidt P.J., Nieman L.K., Danaceau M.A., Adams L.F., Rubinow D.R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N. Engl. J. Med. 1998, 338(4):209-216.
44. Singer J.D., Willett J.B. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence 2003, Oxford University Press.
45. Tabachnick B.G., Fidell L.S. Using Multivariate Statistics 2001, Pearson, New York.
46. Vamvakopoulos G.P.C. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. J. Clin. Investig. 1993, 92(4):1896-1902. 10.1172/JCI116782.
47. Weiser M.J., Handa R.J. Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 2009, 159(2):883-895. 10.1016/j.neuroscience.2008.12.058.
48. Wirth M.M., Schultheiss O.C. Effects of affiliation arousal (hope of closeness) and affiliation stress (fear of rejection) on progesterone and cortisol. Horm. Behav. 2006, 50(5):786-795.